SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000912057-00-006685
Filing Date
2000-02-14
Accepted
2000-02-14 00:00:00
Documents
3
Group Members
BIOTECHNOLOGY VALUE FUND II, L.P.BIOTECHNOLOGY VALUE FUND L PBVF INC.BVF PARTNERS L.P.

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D SC 13D/A 19318
2 EXHIBIT 99A EX-99.A 2177
3 EXHIBIT 99B EX-99.B 4193
  Complete submission text file 0000912057-00-006685.txt   27903
Mailing Address
Business Address 6850 NORTH BROADWAY SUITE G DENVER CO 80221 3036501200
CORTECH INC (Subject) CIK: 0000728478 (see all company filings)

IRS No.: 840894091 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-44313 | Film No.: 542590
SIC: 2834 Pharmaceutical Preparations

Mailing Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606
Business Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE
SIC: 6282 Investment Advice